vs

Side-by-side financial comparison of CorMedix Inc. (CRMD) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.

CorMedix Inc. is the larger business by last-quarter revenue ($128.6M vs $104.1M, roughly 1.2× GRID DYNAMICS HOLDINGS, INC.).

CorMedix Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel therapeutic products for the prevention and treatment of infectious, inflammatory and cardiorenal diseases. Its lead candidate targets catheter-related bloodstream infections, serving critical care and chronic dialysis patient populations primarily across North America and European markets.

Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.

CRMD vs GDYN — Head-to-Head

Bigger by revenue
CRMD
CRMD
1.2× larger
CRMD
$128.6M
$104.1M
GDYN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CRMD
CRMD
GDYN
GDYN
Revenue
$128.6M
$104.1M
Net Profit
$-1.5M
Gross Margin
83.4%
34.8%
Operating Margin
46.0%
61.7%
Net Margin
-1.4%
Revenue YoY
3.7%
Net Profit YoY
-150.6%
EPS (diluted)
$0.20
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRMD
CRMD
GDYN
GDYN
Q1 26
$104.1M
Q4 25
$128.6M
$106.2M
Q3 25
$104.3M
$104.2M
Q2 25
$39.7M
$101.1M
Q1 25
$39.1M
$100.4M
Q4 24
$100.3M
Q3 24
$87.4M
Q2 24
$83.0M
Net Profit
CRMD
CRMD
GDYN
GDYN
Q1 26
$-1.5M
Q4 25
$306.0K
Q3 25
$108.6M
$1.2M
Q2 25
$19.8M
$5.3M
Q1 25
$20.6M
$2.9M
Q4 24
$4.5M
Q3 24
$4.3M
Q2 24
$-817.0K
Gross Margin
CRMD
CRMD
GDYN
GDYN
Q1 26
34.8%
Q4 25
83.4%
34.0%
Q3 25
89.3%
33.3%
Q2 25
95.3%
34.1%
Q1 25
95.9%
36.8%
Q4 24
36.9%
Q3 24
37.4%
Q2 24
35.6%
Operating Margin
CRMD
CRMD
GDYN
GDYN
Q1 26
61.7%
Q4 25
46.0%
0.5%
Q3 25
49.2%
-0.2%
Q2 25
49.2%
-0.1%
Q1 25
51.5%
-2.0%
Q4 24
1.3%
Q3 24
2.4%
Q2 24
0.0%
Net Margin
CRMD
CRMD
GDYN
GDYN
Q1 26
-1.4%
Q4 25
0.3%
Q3 25
104.1%
1.1%
Q2 25
49.9%
5.2%
Q1 25
52.8%
2.9%
Q4 24
4.5%
Q3 24
4.9%
Q2 24
-1.0%
EPS (diluted)
CRMD
CRMD
GDYN
GDYN
Q1 26
$-0.02
Q4 25
$0.20
$0.01
Q3 25
$1.26
$0.01
Q2 25
$0.28
$0.06
Q1 25
$0.30
$0.03
Q4 24
$0.06
Q3 24
$0.05
Q2 24
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRMD
CRMD
GDYN
GDYN
Cash + ST InvestmentsLiquidity on hand
$148.5M
$327.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$405.3M
$530.1M
Total Assets
$826.1M
$605.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRMD
CRMD
GDYN
GDYN
Q1 26
$327.5M
Q4 25
$148.5M
$342.1M
Q3 25
$55.7M
$338.6M
Q2 25
$190.7M
$336.8M
Q1 25
$77.5M
$325.5M
Q4 24
$334.7M
Q3 24
$231.3M
Q2 24
$256.0M
Stockholders' Equity
CRMD
CRMD
GDYN
GDYN
Q1 26
$530.1M
Q4 25
$405.3M
$542.1M
Q3 25
$374.1M
$537.7M
Q2 25
$220.6M
$532.2M
Q1 25
$114.9M
$517.4M
Q4 24
$517.8M
Q3 24
$400.2M
Q2 24
$388.4M
Total Assets
CRMD
CRMD
GDYN
GDYN
Q1 26
$605.0M
Q4 25
$826.1M
$612.9M
Q3 25
$750.9M
$613.2M
Q2 25
$252.6M
$608.9M
Q1 25
$149.6M
$590.9M
Q4 24
$592.2M
Q3 24
$477.3M
Q2 24
$443.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRMD
CRMD
GDYN
GDYN
Operating Cash FlowLast quarter
$94.5M
Free Cash FlowOCF − Capex
$92.7M
FCF MarginFCF / Revenue
72.1%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$172.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRMD
CRMD
GDYN
GDYN
Q1 26
Q4 25
$94.5M
$9.9M
Q3 25
$30.9M
$7.0M
Q2 25
$30.0M
$14.4M
Q1 25
$19.7M
$9.4M
Q4 24
$7.1M
Q3 24
$9.2M
Q2 24
$10.7M
Free Cash Flow
CRMD
CRMD
GDYN
GDYN
Q1 26
Q4 25
$92.7M
$6.1M
Q3 25
$30.4M
$2.9M
Q2 25
$30.0M
$10.2M
Q1 25
$19.7M
$6.0M
Q4 24
$4.4M
Q3 24
$5.9M
Q2 24
$8.0M
FCF Margin
CRMD
CRMD
GDYN
GDYN
Q1 26
Q4 25
72.1%
5.7%
Q3 25
29.1%
2.8%
Q2 25
75.4%
10.1%
Q1 25
50.5%
6.0%
Q4 24
4.4%
Q3 24
6.8%
Q2 24
9.7%
Capex Intensity
CRMD
CRMD
GDYN
GDYN
Q1 26
Q4 25
1.3%
3.6%
Q3 25
0.5%
3.9%
Q2 25
0.1%
4.1%
Q1 25
0.0%
3.3%
Q4 24
2.6%
Q3 24
3.7%
Q2 24
3.2%
Cash Conversion
CRMD
CRMD
GDYN
GDYN
Q1 26
Q4 25
32.34×
Q3 25
0.28×
5.92×
Q2 25
1.51×
2.73×
Q1 25
0.96×
3.21×
Q4 24
1.56×
Q3 24
2.15×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRMD
CRMD

Acquisition Of Melinta$52.9M41%
Melinta Portfolio$45.5M35%
Other$18.6M14%
Contract Revenue$7.4M6%
BARDA Agreement$4.2M3%

GDYN
GDYN

Segment breakdown not available.

Related Comparisons